To study the role of ions in the release of Prolactin (PRL), several experiments were performed utilizing dispersed pituitary cells obtained from adult, female Sprague-Dawley rats. All tests were done after a culture period of 5 days in multiwell Petri plates at 3 x 10 5 cells per well. Culture medium was Dulbecco's modified Eagle's medium (DMEN) supplemented with 10% horse serum, 2.5% fetal calf serum, non-essential amino-acids and antibiotics. PRL secretion was measured by specific RIA after 4 h of test incubstion in various media at 37 0 in a COz/air incubator. Basal PRL secretion in DMEN (154±12 ng/ml) was drastically reduced in a hypoosmolar, sodium deprived medium (48±4 ng/ml) , remained low when NaCl was replaced by isoosmolar concentrations of glucose (33±2 ng/ml), and was restored by the addition of either sodium or choline 110 mM. When DA 10-11Mwas added to the medium with sodium, an 83% increment of PRL secretion was observed, while the neurotransmitter was completely inactive in absence of NaCI. DA 5 x 10-6M strongly inhibited PRL release in the presence of sodium but was inactive either in the absence of the ion or when the ion channel was blocked by tetrodotoxin (TTX). Baseline and DA-stimulated PRL release were also strongly inhibited by the addition to the medium of either Co++ (a calcium channel blocker) or TTX. These results indicate that a normal ionic charge in the medium is essential for baseline PRL secretion, while both sodium and calcium ions are necessary for DA control of hormone release. The efficacy of Tr.M. in the treatment of C.D. in children and adolescents has not been assessed. We treated 8 patients (7-6/12-18-9/12 yrs old) with C.D. by Tr.M. (followup 8-72 months postoperatively). Growth failure and weight gain were the first signs of C.D.; pubertal delay, virilization and fatigability were variable features. Preoperative evaluation showed elevated urinary free cortisol and no diurnal variation in plasma cortisol or ACTH values; high dose dexamethasone therapy suppressed excretion of urinary free cortisol. Two of 8 patients lacked definite radiographic evidence of a pituitary adenoma. Transphenoidal exploration revealed 1-4 mm adenomas in 7 of 8 patients; no definite adenoma was noted in the 8th patient in spite of CT scan evidence of adenoma. Postoperative complications were limited to transient diabetes insipidus. The 7 treated patients had low cortisol and ACTH secretion postoperatively and required replacement glucocorticoid therapy for 6-12 months. Weight loss, growth and pubertal progression without recurrence of C.D. were noted in 6 patients with long term followup. Our experience indicates that ACTH secreting microadenomas are the principal cause of C.D. in childhood and adolescence and suggests that transphenoidal microadenectomy is the initial treatment of choice for Cushing's disease in young patients . 
Idiopathic 01 is associated, by definitian, with no obviaus organic lesion. Despite negative clinical and neuraradiological investigatians, the questian remains of the tumoral arigin of the disease, mainly if anteriar pituitary dysfunction is demonstrated. The purpase of this study was to evoluate the course and sivnificance of this association. 26 patients (6 familial) were investigated, with a fallowup af 4-20 yrs (x= 12.5 yrs) after onset af polyuria. Pneumoencephalography (n= 27) and/or CT scan (n= 11) were normal.
GH deficiency was present in 10/26 cases. Recovery, not related to puberty in all cases, was observed in 5 patients. TSH response to TRF (n= 17) was deficient (n= 3) or af the hypothalamic type (n= .). Puberty was normal in 17 cases, ond abnormal in 2 cases (respectively precociaus and slowly progressing). GH deficiency was isolated in 5 cases or associated with ACTH +TSH (n= 1), TSH (n= 1), ACTH (n= 3) abnarmalities.
In canclusion : lang term abservatian is necessary to ascerta1n the d1agnosis of idiapathic 01. Anterior pituitary deficiency may be associoted, without any evidence of tumor. GH deficiency may be transient. These findings suggest that hypothalamic disturbances leading ta idiapathic 01 involve more that the hypothalamic posteriar pituitary system itself. injections. 'Ihe high rurity of the present IlGII preparations makes s,c, administration an attractive alternative enabling selfadministration. In this study time courses of pla!l1la IlGII after s.c and 1.m.injections of highly rurified IlGII (Naoonron R) are described and carpared to the diurnal pkasma IlGII profile in eight ooIlllal children (11-14 years). Seven pat.Ienta suffering fran idiap3.thic HGI-deficient dwarfisn (age 10-19 years) received 1.m. and s ,c, injection of IlGII in the IlDrning (4IU/rn2) in raman order with an interval of one week. r.m, injections lead to a peak HGI eoncentration at 2 InJrs (mean 204,range 135-475 rg/rnl) with a return to baseline 8-10 InJrs after injection.correspondingly IlGII concentration peaked at 4 hrs (mean 38,range 15-68 rg/rnl)after s .c , injection and returned to baseline alx>ut 18 bours after injection. In a subseauent study on similar pat.Ienta (n=7,age 10-19 years) IlGII (2IU/rn2) was injected s ,c , in the evening.1lGII concentration peaked at 5 bours (mean l7,range 7-28 rg/rnl) and returned to baseline 14 bours after injection.'lhe results indicate that absorption fran an 1.m. depot is far too slv:>rt to give a p,ysiological diurnal profile of IlGII in plasna -even by daily administration. However, daily s ,c, injection will,if given in the evening,imitate oonnal oocturnal IlGII profile.
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Dept. of Pediatrics, University of Zurich, Switzerland "A-type" isolated growth honnone deficiency (IGHD). In 1970, we presented the "A-type" of autosomal receuive IGHD characterized by early and severe growth retordatian, typical face with vaulted farehead, a strong metabolic and g.-th response to exogenous hGH, and a tendency to fann high GH antibodies which abol ish this effect.
Recent events prompt us to report on these patients again: 1) Philipps et al (abstr.Ped.Res. 1981) carried out restriction endonuclease studies In our original family A, yielding abnonnal DNA patterns of the GH genes. In other families with IGHO, they found a nonnal pattern. 2) One of our female patients of the same family (26 years, 118 em) gave birth to a healthy girl (GA 40 weeks, 2370 g, 43 em], GH antibodies were found not only In the mother (12 years after the end of hGH~) but also in the newborn. Five months later, no mare antibodies were detectoble. 3) In another family we succeeded for the first time to treat a 5 year-old boy with hGH aver a period of 1.5 years without the appearance of HG antibodies so far. This is In contrast to his 10 year-old brother previously treated with a different hGH preparation who developped high titre, growth-inhibiting GH antibodies. It appears that certain hGH preporations are tolerated by th_ patients who presumobly suffer from a prenatal GH deficiency which may cause a lack of immunotolerance for hGH. Supported by the Swiu Notional Science Foundation Grant No. 3.901.0n 
